i took cme course medical cannabis clinical applications evidence health professionals april pm done collaboration university minnesota center spirituality healing minnesota department health office medical cannabis minnesota nd state legislate version medical cannabis conference showcased minnesota version state federal regulatory landscape available evidence support use cannabis certain conditions politics medical cannabis also display viewpoints experts panel represented scientific data also complementary approaches little science minnesota approach interesting one may prove provide cannabis products offer relatively standardized dose tetrahydrocannabinol thc cannabidiol cbd combination minnesota two companies exclusive providers non smokable cannabis products extracted entire plant leafline labs minnesota medical solutions extraction process entirely carbon dioxide based hydrocarbons used strict quality control measures smokable combustible cannabis products state according statute medical cannabis available oil pill vapor oil liquid dried leaves plant form form approved commissioner excluding smoking two companies supply state operated pharmacies dispense cannabis products order person access products need register state pay annual fee certified eligible condition physician recommends rather prescribes product patient discusses actual product used pharmacist pays product insurance companies state programs pay cannabis speakers venue highly qualified donald abrams md adult oncologist years experience gave lectures medical cannabis endocannabinoid system clinical applications cannabis cancer care highly informative one people access cannabis grown nida national institute drug abuse go regulatory maze allows researchers use clinical trials discussed concept i never heard called entourage effect entourage effect defined benefits using whole cannabis plant rather specific compounds theory compounds broad mix enhance overall effect active ingredients pharmacokinetic pharmacodynamic effects described one principles chinese medicine course allopathic medicine practice emphasized benefits delivery smoke vapor rather oral forms largely due rapid onset action rapid adjustment dose compared oral forms presented data show particular volcano style vaporizer consistently deliver therapeutic amounts cannabis patient determined recommended delivery system patients michael bostwick md mayo clinic psychiatrist gave two excellent presentations medical cannabis barriers myths evidence medical cannabis statutes role federal government one biases discussed dr bostwick seminar common observation advocates see cannabis cure everything scant data useful indicated conditions course bias may also reflect mixed agenda recreational cannabis advocates seeking legitimize cannabis medicine open door eventual widespread legalization endeavor science would expected casualty bias hysteria adverse medical societal effects cannabis use least attitudes may resulted racist attitudes images reefer madness shown emblematic spirit times exercise much different meaning today good portion audience seeing knowing eager laugh ignorance archaic movie applaud speaker advocated removal barriers medical non medical cannabis use problem i sitting audience watching reefer madness acting way bottom line biases clear effects legislation led cannabis going listed pharmacopeia hundred years schedule i dea list controlled substances countervailing fact cannabis around years clear medical indication mentioned historical fact potential rationale schedule i listing plenty optimism discovery endocannabinoid system getting cannabis restrictive controlled substance category would lead whole new era useful medicinal compounds dr bostwick discussion regulatory landscape cannabis superb i teach subject myself somehow aware two memos justice department i practical aspects enforcing controlled substances context increasing legalization state level described states going rogue i thought humorous also carefully laid fda regulatory process really set approval botanicals researchers interested using cannabis research purposes ilo leppik md long time neurologist epileptologist twin cities thirty three years ago i intern one neurology services town attending physician time noticed basic science research cbd potential anticonvulsant properties tried unsuccessfully get pharmaceutical companies interested compound years discussed currently available research single company trying get fda approval cannabis derived approach treating seizures also advocate getting neurological colleagues involved registered certifiers medical cannabis epileptologists treat refractory seizure disorders adequately respond measures population dr leppik would use medical cannabis presented supporting data well known publicized case pediatric patient seizures discussed dr leppik case frequently cited pro cannabis advocates proof cannabis legitimate medication needs broader use pointed patient seizure disorder purported dravet syndrome also seen top epileptologist state resided went present case practice childhood epilepsy misdiagnosed made correct diagnosis point patient mother insisted stay cbd along correct anticonvulsant condition patient eventually ran cbd seizures remained remission put correct standard anticonvulsant correct diagnosis case valproate angela birnbaum phd pharmacologist presented science day straightforward pharmacokinetic principles apply treating patients epilepsy approach also highlighted advantages using minnesota approach medical cannabis way assure steady levels drug necessary treat epilepsy dr birnbaum also presented graphic similar one product types available minnesota companies detailed information available company web sites shown susan sencer md presented medical cannabis perspective pediatric oncologist relatively new medical cannabis laws minnesota pediatric hospital certified use pediatric patients cancer diagnoses guy acute care psychiatrist addiction psychiatrist working life clearly biases operating conference people seemed aware cannabis discussed nearly benign product sure know endocannabinoid system something brain development sure could lead psychosis early onset psychosis probably people predisposed psychosis remarks none panelists recommended medical cannabis followed adult patients cannabis ever seen develop acute psychosis jokes made implausibility amotivational syndrome opinion panelists side effects generally benign even though data presented clinical trials suggesting otherwise i looked clinicians represented panel treated patients cannabis two oncologists neurologist psychiatrist specialized treating chronic pain psychiatrist talked treating people psychotic disorders one point slide suggested chronic psychotic disorders might contraindication use cannabis data presented description practices suggested me strong selection bias present panelists seeing psychiatric complications problems addictions treating anyone psychiatric disorders addictions guys like me see patients last thing want see somebody giving patients cannabis i think much different story list eligible conditions expanded include insomnia anxiety depression posttraumatic stress disorder like states list medical personnel authorized certify use medical cannabis expands expanding indication chronic pain bring patient population probably distinctly different patient base panelists treating i written blog many times i like idea medical cannabis exact reason one panelists mentioned always political manipulation legalization recreational marijuana want advocate legalization recreational marijuana fine me drag physicians pretend allopathic medicine reference came conference many times referred botanical therefore awkward fda regulatory scheme time i problem oncologists neurologists telling patients use i going pretend significant psychiatric morbidity extends far beyond activating psychosis predisposed i imagine many colleagues find discover patients cannabis added list medications many panelists discover start seeing significant numbers patients psychiatric problems addictions despite politics bias underlying science supports medical cannabis minnesota rational approach toward implementing addiction psychiatric side effects compounds always limiting factor case case every addicting medication best solution avoid try something else george dawson md dfapa references bostwick jm need reschedule cannabis sane solution irrational standoff minn med apr pubmed pmid bostwick jm use cannabis management chronic pain gen hosp psychiatry jan feb doi genhosppsych epub oct pubmed pmid bostwick jm reisfield gm dupont rl clinical decisions medicinal use marijuana engl med feb doi nejmclde epub feb pubmed pmid bostwick jm blurred boundaries therapeutics politics medical marijuana mayo clin proc feb doi mayocp review pubmed pmid pubmed central pmcid pmc abrams di guzman cannabis cancer care clin pharmacol ther jun doi cpt epub apr review pubmed pmid hazekamp ware muller vahl kr abrams grotenhermen f medicinal use cannabis cannabinoids international cross sectional survey administration forms psychoactive drugs jul aug pubmed pmid abrams di couey p shade sb kelly me benowitz nl cannabinoid opioid interaction chronic pain clin pharmacol ther dec doi clpt epub nov pubmed pmid carter flanagan earleywine abrams di aggarwal sk grinspoon l cannabis palliative medicine improving care reducing opioid related morbidity hosp palliat care aug doi epub mar review pubmed pmid abrams di vizoso hp shade sb jay kelly me benowitz nl vaporization smokeless cannabis delivery system pilot study clin pharmacol ther nov epub apr pubmed pmid abrams di jay ca shade sb vizoso reda press kelly me rowbotham mc petersen kl cannabis painful hiv associated sensory neuropathy randomized placebo controlled trial neurology feb pubmed pmid carter weydt p kyashna tocha abrams di medicinal cannabis rational guidelines dosing idrugs may review pubmed pmid andreae mh carter gm shaparin suslov k ellis rj ware abrams di prasad wilsey indyk johnson sacks hs inhaled cannabis chronic neuropathic pain meta analysis individual patient data pain dec doi jpain epub sep pubmed pmid pubmed central pmcid pmc arneson insights review medical cannabis clinical trials minn med jun review pubmed pmid health canada web page consumer information cannabis health canada information health care professionals cannabis marihuana marijuana cannabinoids highly regarded report panelists conference version update pending time katona i cannabis endocannabinoid signaling epilepsy handb exp pharmacol doi review pubmed pmid devinsky marsh friedman thiele laux l sullivan miller i flamini r wilfong filloux f wong tilton bruno p bluvstein hedlund kamens r maclean nangia singhal ns wilson ca patel cilio mr cannabidiol patients treatment resistant epilepsy open label interventional trial lancet neurol mar doi epub dec pubmed pmid reddy ds golub vm pharmacological basis cannabis therapy epilepsy pharmacol exp ther apr doi jpet epub jan pubmed pmid tzadok uliel siboni linder i kramer epstein menascu nissenkorn yosef ob hyman granot dor lerman sagie ben zeev cbd enriched medical cannabis intractable pediatric epilepsy current israeli experience seizure feb doi seizure epub jan pubmed pmid blair deshpande ls delorenzo rj cannabinoids potential treatment role epilepsy expert opin pharmacother epub aug pubmed pmid pubmed central pmcid pmc rosenberg ec tsien rw whalley bj devinsky cannabinoids epilepsy neurotherapeutics oct doi pubmed pmid pubmed central pmcid pmc kaur r ambwani sr singh endocannabinoid system multi facet therapeutic target curr clin pharmacol apr epub ahead print pubmed pmid leo russo elia cannabidiol epilepsy rationale therapeutic potential pharmacol res mar doi phrs epub ahead print pubmed pmid volkow nd baler rd compton wm weiss srb adverse health effects marijuana use engl med june doi nejmra supplementary time saturday afternoon i still waiting link presentations i plan add detailed information point information i recall direct observation soon i links i able list actual medical cannabis products minnesota available medical cannabis web site one sites either manufacturers stay tuned graphic containing information supplementary one jokes addiction specialists conference like orthopedic surgeons bottom ski hill obvious implication see train wrecks implication non addiction specialists prescribe addictive drugs concerns addiction usually ok people make safely bottom ski hill course time already presented data people use cannabis get addicted almost young panelists general impressions patients problem addiction never disagreement terminally ill patients addiction concern chronic pain patients without terminal illness much different problem ethical problem me may obligation make sure skiers negotiate hill sell ticket also recent precedent declaring prescribing practices conservative based addiction risk happened right current prescription opioid epidemic based seriously flawed studies addiction supplementary want best single reference subject go health canada monograph reference read currently available document wait update free download supplementary marijuana cannabinoids nih sponsored neuroscience summit march link archived video recordings